Q SQUARED SOLUTIONS HOLDINGS LIMITED
Get an alert when Q SQUARED SOLUTIONS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£432k
-41.5% vs 2024
Net assets
£293m
+7.9% highest in 3 filed years
Employees
0
Average over period
Profit before tax
£21m
-75.2% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£5,000 | -£7,000 | £0 | +100% | |
| Profit before tax | £32,019,000 | £86,332,000 | £21,423,000 | -75.2% | |
| Net profit | £31,885,000 | £86,467,000 | £21,423,000 | -75.2% | |
| Cash | £80,000 | £738,000 | £432,000 | -41.5% | |
| Total assets less current liabilities | £256,813,000 | £271,280,000 | — | — | |
| Net assets | £256,813,000 | £271,280,000 | £292,703,000 | +7.9% | |
| Equity | £256,813,000 | £271,280,000 | £292,703,000 | +7.9% | |
| Average employees | 0 | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £0 | £0 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | -0.0% | -0.0% | — | |
| Current ratio | 14.55x | 19.98x | 28.40x | |
| Interest cover | -0.04x | — | — |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- Q SQUARED SOLUTIONS HOLDINGS LIMITED 2015-07-01 → present
- CLINICAL LAB JV LIMITED 2015-06-12 → 2015-07-01
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.”
Group structure
- Q SQUARED SOLUTIONS HOLDINGS LIMITED · parent
- Clinical Lab Minority Shareholder Limited 100%
- Q Squared Solutions China (Quest) Limited 100%
- Q Squared Solutions Proprietary Limited 100%
- Q Squared Solutions China Limited 100%
- Q Squared Solutions Holding BV 100%
- Q Squared Solutions KK 100%
- Q Squared Solutions Pte Ltd 100%
- Q Squared Solutions Limited 100%
- Q Squared Solutions S.A. 90%
- Q Squared Solutions BV 100%
- Q Squared Solutions (Beijing) Co.Limited 100%
- Q Squared Solutions S.A. 10%
- Nexelis Europe 100%
- ImmunXperts 100%
- Nexelis Marburg GmbH 100%
Significant events
- “On 1 April 2025, IQVIA Biotech Ltd, a fellow group undertaking acquired the 40% minority share of Q Squared Solutions Holdings Limited from Quest Diagnostics Subsidiary Holdings Ltd for £253,520,333, resulting in 100% ownership by IQVIA.”
- “On 30 October 2024, the company acquired the remaining 10% shareholding in Q Squared Solutions China Limited, 6% from IQVIA LTD and 4% from IQVIA Biotech Ltd. The company issued 10 ordinary £0.00001 shares (6 shares to IQVIA LTD and 4 shares to IQVIA Biotech Ltd) for this acquisition.”
- “On 3 June 2025, the company acquired the entire issued share capital of Nexelis Europe from Nexelis Group LLC for a consideration of £3.00.”
- “On 25 February 2026, the company entered into an agreement to acquire the Laboratory business from Charles River Laboratories for a consideration of £94,139,405 ($12,492,406).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WILLIFORD, John | Secretary | 2020-01-01 | — | — |
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-29 | — | — |
| LOWEY, Elaine | Director | 2024-07-31 | Oct 1978 | British |
| THORNLEY, Simon Carwyn | Director | 2022-08-25 | Feb 1972 | British |
| TURLAND, Kevin John | Director | 2022-08-25 | Mar 1969 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BROOKS, Marc | Secretary | 2015-07-01 | 2017-02-08 |
| ESTRADA, Santiago | Secretary | 2017-02-09 | 2019-12-31 |
| FOVARGUE, Helen | Secretary | 2017-02-09 | 2019-11-01 |
| BROWN, Tony | Director | 2022-08-25 | 2024-07-31 |
| BROWN STAFFORD, Paula | Director | 2015-07-01 | 2016-01-01 |
| BRUEHLMAN, Ronald Earl | Director | 2017-02-09 | 2022-08-25 |
| FONSECA, Lidia | Director | 2017-02-09 | 2019-02-13 |
| FUNK, Randy Lee | Director | 2019-02-11 | 2021-04-01 |
| GORDON, Kevin Karl | Director | 2015-07-01 | 2016-10-03 |
| GUINAN, Mark James | Director | 2018-05-17 | 2021-04-01 |
| HAYDON, John Bradley | Director | 2015-07-01 | 2018-05-17 |
| LORENZ, Rene | Director | 2016-10-04 | 2022-08-25 |
| MACDONALD, Alasdair | Director | 2015-06-12 | 2015-07-01 |
| NORMAN, Jay | Director | 2015-07-01 | 2017-02-08 |
| PANAGOS, Constantinos | Director | 2017-02-09 | 2018-09-10 |
| RALPHSON, Neil | Director | 2015-07-01 | 2018-05-17 |
| SHORTEN, Dermot Victor | Director | 2015-07-01 | 2017-02-08 |
| SPAEDER, Jeffrey | Director | 2020-06-05 | 2022-08-25 |
| STEWART, Wendy | Director | 2018-05-17 | 2022-08-25 |
| VERST, Cynthia | Director | 2018-09-10 | 2020-06-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Iqvia Biotech Ltd. | Corporate entity | Shares 25–50%, Voting 25–50% | 2021-04-01 | Active |
| Quest Diagnostics Subsidiary Holdings Ltd | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2021-04-01 |
| Iqvia Ltd. | Legal person | Shares 50–75% | 2016-04-06 | Ceased 2016-04-06 |
| Iqvia Ltd. | Corporate entity | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 106 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-09 | AA | accounts | Accounts with accounts type full | |
| 2026-06-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-08 | AA | accounts | Accounts with accounts type full | |
| 2025-06-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-12-10 | SH01 | capital | Capital allotment shares | |
| 2024-12-09 | SH01 | capital | Capital allotment shares | |
| 2024-08-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-10 | AA | accounts | Accounts with accounts type full | |
| 2024-06-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-06 | CH01 | officers | Change person director company with change date | |
| 2023-10-09 | AD02 | address | Change sail address company with old address new address | |
| 2023-10-06 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2023-07-15 | AA | accounts | Accounts with accounts type full | |
| 2023-06-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-19 | AAMD | accounts | Accounts amended with accounts type full | |
| 2022-09-07 | AA | accounts | Accounts with accounts type full | |
| 2022-08-31 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-31 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-31 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.